Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1989-08-18
1992-05-05
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 72, 536 74, A61K 3170, C07H 1708
Patent
active
051108003
ABSTRACT:
Three new groups of 9-N-substituted derivatives of erythromycylamine with superior oral activity against Gram-positive pathogens, new processes for preparing derivatives of erythromycylamine and aliphatic aldehydes by controlling the pH of the reaction and by catalytic hydrogenation, and pharmaceutical compositions and methods using the new compounds are provided.
REFERENCES:
patent: 3652537 (1972-03-01), Massey et al.
patent: 3660376 (1972-05-01), Massey
patent: 3681322 (1972-08-01), Kitchell et al.
patent: 3772270 (1973-11-01), Gerzon et al.
patent: 3780019 (1973-12-01), Wildsmith
patent: 3780020 (1973-12-01), Evans
patent: 3790559 (1974-02-01), Wildsmith
patent: 3794635 (1974-02-01), Evans
patent: 4016263 (1977-04-01), Wetzel et al.
patent: 4048306 (1977-09-01), Maier et al.
patent: 4256738 (1981-03-01), Woitun et al.
Massey et al. "Erythromycylamine", Tetrahedron Letters 1970 (2), 157-160.
Ryden et al., "N-Substituted Derivatives of Erythromycylamine," J. Med. Chem. 16 (9), 1059-1060 (1973).
Cockerill et al., "Substituent Effects on the pKa Values and Rates of Hydrolysis of Aryl-methylene-erythromycylamines," J. Chem. Soc. Perkin, II 1973, 173-179.
Massey et al., "Antibacterial Activity of 9(S)-erythromycylamine-Aldehyde Condensation Products," J. Med. Chem. 17, 105-107 (1974).
Vince et al., "Binding of N-Substituted Erythromycylamine to Ribosomes," Antimicrobial Agents and Chemotherapy 9 (1), 131-136 (1976).
Bonjouklian Rosanne
Debono Manuel
Kirst Herbert A.
Wind Julie A.
Brown Johnnie R.
Eli Lilly and Company
Harrison Nancy J.
Peselev Elli
Whitaker Leroy
LandOfFree
Derivatives of erythromycylamine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of erythromycylamine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of erythromycylamine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1412517